BreeAnn N. Brandhagen, Ph.D.
Affiliations: | 2012 | Basic Biomedical Sciences | University of South Dakota, Vermillion, SD, United States |
Area:
Cell Biology, OncologyGoogle:
"BreeAnn Brandhagen"Parents
Sign in to add mentor| David C Arnett | research assistant | Northwestern College Iowa (Chemistry Tree) | ||
| Carlos M. Telleria | grad student | 2012 | University of South Dakota | |
| (Anti-metastatic properties of mifepristone in cancer cells.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Ritch SJ, Brandhagen BN, Goyeneche AA, et al. (2019) Advanced assessment of migration and invasion of cancer cells in response to mifepristone therapy using double fluorescence cytochemical labeling. Bmc Cancer. 19: 376 |
| Brandhagen BN, Tieszen CR, Ulmer TM, et al. (2013) Cytostasis and morphological changes induced by mifepristone in human metastatic cancer cells involve cytoskeletal filamentous actin reorganization and impairment of cell adhesion dynamics Bmc Cancer. 13 |
| Brandhagen BN, Tracy MS, Goyeneche AA, et al. (2012) Abstract 344: Mifepristone alters morphology, cytoskeletal architecture, and epithelial-mesenchymal transition-related proteins in human metastatic cancer cells Cancer Research. 72: 344-344 |
| Tieszen CR, Goyeneche AA, Brandhagen BN, et al. (2011) Antiprogestin mifepristone inhibits the growth of cancer cells of reproductive and non-reproductive origin regardless of progesterone receptor expression. Bmc Cancer. 11: 207 |
| Tieszen CR, Goyeneche AA, Brandhagen BN, et al. (2011) Abstract 4546: Antiprogestin mifepristone inhibits the growth of cancer cells of reproductive and non-reproductive origin regardless of progesterone receptor expression Cancer Research. 71: 4546-4546 |
| Brandhagen BN, Tieszen CR, Telleria CM, et al. (2011) Abstract 2362: Antimetastatic potential of the antiprogestin mifepristone in cancer cells Cancer Research. 71: 2362-2362 |